Wedbush Securities’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $920K | Buy |
2,379
+47
| +2% | +$17.4K | 0.02% | 511 |
|
|
2026
Q1 | $683K | Buy |
2,332
+107
| +5% | +$35.2K | 0.02% | 583 |
|
|
2025
Q4 | $780K | Sell |
2,225
-69
| -3% | -$23.3K | 0.02% | 526 |
|
|
2025
Q3 | $741K | Sell |
2,294
-173
| -7% | -$53.8K | 0.02% | 526 |
|
|
2025
Q2 | $960K | Sell |
2,467
-153
| -6% | -$61.5K | 0.03% | 425 |
|
|
2025
Q1 | $1.14M | Buy |
2,620
+8
| +0.3% | +$3.21K | 0.04% | 356 |
|
|
2024
Q4 | $963K | Sell |
2,612
-384
| -13% | -$161K | 0.03% | 387 |
|
|
2024
Q3 | $1.56M | Sell |
2,996
-835
| -22% | -$446K | 0.06% | 243 |
|
|
2024
Q2 | $2.08M | Sell |
3,831
-22
| -0.6% | -$11.6K | 0.07% | 189 |
|
|
2024
Q1 | $2M | Buy |
3,853
+573
| +17% | +$285K | 0.07% | 209 |
|
|
2023
Q4 | $1.55M | Sell |
3,280
-114
| -3% | -$52.7K | 0.07% | 213 |
|
|
2023
Q3 | $1.48M | Sell |
3,394
-175
| -5% | -$79.4K | 0.07% | 205 |
|
|
2023
Q2 | $1.59M | Buy |
3,569
+151
| +4% | +$69.7K | 0.08% | 201 |
|
|
2023
Q1 | $1.57M | Sell |
3,418
-115
| -3% | -$54.7K | 0.08% | 198 |
|
|
2022
Q4 | $1.81M | Sell |
3,533
-498
| -12% | -$253K | 0.1% | 166 |
|
|
2022
Q3 | $1.83M | Buy |
4,031
+1,469
| +57% | +$703K | 0.1% | 154 |
|
|
2022
Q2 | $1.24M | Buy |
2,562
+14
| +0.5% | +$6.93K | 0.07% | 244 |
|
|
2022
Q1 | $1.25M | Sell |
2,548
-379
| -13% | -$173K | 0.06% | 285 |
|
|
2021
Q4 | $1.36M | Sell |
2,927
-606
| -17% | -$255K | 0.06% | 284 |
|
|
2021
Q3 | $1.32M | Sell |
3,533
-108
| -3% | -$41K | 0.06% | 289 |
|
|
2021
Q2 | $1.39M | Buy |
3,641
+83
| +2% | +$31.7K | 0.07% | 276 |
|
|
2021
Q1 | $1.28M | Buy |
+3,558
| New | +$1.14M | 0.07% | 267 |
|
|
2020
Q4 | – | Sell |
-3,230
| Closed | -$867K | – | 902 |
|
|
2020
Q3 | $867K | Sell |
3,230
-69
| -2% | -$18.6K | 0.08% | 247 |
|
|
2020
Q2 | $867K | Buy |
3,299
+466
| +16% | +$124K | 0.08% | 250 |
|
|
2020
Q1 | $643K | Buy |
2,833
+327
| +13% | +$89.1K | 0.08% | 287 |
|
|
2019
Q4 | $757K | Buy |
2,506
+277
| +12% | +$76.2K | 0.07% | 332 |
|
|
2019
Q3 | $535K | Buy |
2,229
+119
| +6% | +$32.6K | 0.05% | 420 |
|
|
2019
Q2 | $595K | Buy |
2,110
+285
| +16% | +$77.9K | 0.06% | 367 |
|
|
2019
Q1 | $524K | Sell |
1,825
-36
| -2% | -$10.4K | 0.06% | 390 |
|
|
2018
Q4 | $489K | Sell |
1,861
-137
| -7% | -$37.7K | 0.06% | 360 |
|
|
2018
Q3 | $548K | Buy |
1,998
+167
| +9% | +$43.4K | 0.06% | 364 |
|
|
2018
Q2 | $436K | Buy |
1,831
+652
| +55% | +$151K | 0.05% | 419 |
|
|
2018
Q1 | $259K | Buy |
+1,179
| New | +$277K | 0.03% | 585 |
|
Other funds holding ELV
Wedbush Securities's ELV Position: Q2 2026 in Review
Wedbush Securities increased its Elevance Health (ELV) stake by 2% in Q2 2026, buying an estimated $17.4K and bringing the position to 2,379 shares worth $920K. The position accounts for 0.02% of the portfolio, ranked #511.
Wedbush Securities first reported a position in ELV in Q1 2018 and has held it in 33 quarters since. The position peaked at $2.08M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Wedbush Securities held 2,379 shares of Elevance Health worth $920K as of Q2 2026.
- Wedbush Securities bought 47 Elevance Health shares in Q2 2026, an estimated $17.4K.
- Elevance Health made up 0.02% of Wedbush Securities's portfolio in Q2 2026, its #511 holding.
- Wedbush Securities first reported a position in Elevance Health in Q1 2018 and has held it in 33 quarters since.
- Wedbush Securities's Elevance Health position peaked at $2.08M in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.